Genotyping is the method of studying DNA sequence to determine genetic structure in the genotypes of living organisms such as humans, plants, animals, and microorganisms. Genotyping helps in preventing of spreading of pathogens by tracking down the origin of occurrence. The global genotyping market will be growing at a CAGR of 22.3% to reach $44.7 Billion by 2025 from $13.55 Billion in 2019 during the forecast period. The prominent factors leading the market growth are increased incidence and awareness of genetic diseases and personalised medicine, high usage of genetic analysis in animal & plant livestock, and growing demand for pharmacogenomics in drug discovery. However, lack of well-trained personnel and reimbursement issues are restraining the market growth. Growing demand for affordable genotyping services, increasing access to healthcare & government investments by key players are creating profitable opportunities to the genotyping market growth.

Research Study Objectives:

• Define, estimate, and forecast the genotyping market statistics by product& service, technology, application, end user, and regions concerning the individual growth drivers, market trends and their contribution toward the genotyping market growth.
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints &Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the genotyping market Analysis report.
• Analysis and conclusions on the future genotyping market outlook.

Top-down and bottom-up approaches are used to validate the genotyping market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Business week, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The genotyping market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the genotyping market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The genotyping market segmentation is as follows:

By Product & Services

• Instruments
  • Sequencers & Amplifiers
  • Analyzers
• Reagents &Kits
• Genotyping Services
• Bioinformatics Software

By Technology

• PCR (Polymerase Chain Reaction)
  • Real-Time PCR
  • Digital PCR
• Sequencing
  • Next Generation Sequencing
  • Sanger Sequencing
  • Pyrosequencing
• Microarray
• Allele-Specific Oligonucleotide Probes
• Capillary Electrophoresis
  • Restriction Fragment Length Polymorphism
  • Amplified Fragment Length Polymorphism
  • Single Strand Conformation Polymorphism
• Others

By Application

• Animal Genetics
• Diagnostic Research
• Agricultural Biotechnology
• Pharmacogenomics
• Others

By End User

• Biopharmaceutical & Biotechnology Companies
• Research Laboratories and Institutes
• Others

Geographical Analysis:

Genotyping market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customizations Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the genotyping market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Genotyping Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant genotyping market players, such as
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Affymetrix, Inc.
  • Thermo Fisher Scientific
  • QIAGEN N.V.
• Along with these companies, many other companies are considered in the report while analysing the global genotyping competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.